Xu Qiuyue, Jiang Mingchen, Gu Simeng, Wang Fushun, Yuan Bin
School of Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Department of Psychology, Jiangsu University Medical School, Zhenjiang, China.
Front Cell Dev Biol. 2020 Sep 8;8:582247. doi: 10.3389/fcell.2020.582247. eCollection 2020.
Major depressive disorder (MDD) is coming to be the regarded as one of the leading causes for human disabilities. Due to its complicated pathological process, the etiology is still unclear and the treatment is still targeting at the monoamine neurotransmitters. Early life stress has been known as a major cause for MDD, but how early life stress affects adult monoaminergic activity is not clear either. Recently, DNA methylation is considered to be the key mechanism of epigenetics and might play a role in early life stress induced mental illness. DNA methylation is an enzymatic covalent modification of DNA, has been one of the main epigenetic mechanisms investigated. The metabolic enzyme for the monoamine neurotransmitters, monoamine oxidases A/B () are the prime candidates for the investigation into the role of DNA methylation in mental disorders. In this review, we will review recent advances about the structure and physiological function of monoamine oxidases (MAO), brief narrative other factors include stress induced changes, early life stress, perinatal depression (PD) relationship with other epigenetic changes, such as DNA methylation, microRNA (miRNA). This review will shed light on the epigenetic changes involved in MDD, which may provide potential targets for future therapeutics in depression pathogenesis.
重度抑郁症(MDD)正逐渐被视为导致人类残疾的主要原因之一。由于其病理过程复杂,病因仍不明确,治疗仍以单胺类神经递质为靶点。早年生活应激一直被认为是MDD的主要病因,但早年生活应激如何影响成年期单胺能活性也尚不清楚。最近,DNA甲基化被认为是表观遗传学的关键机制,可能在早年生活应激诱发的精神疾病中起作用。DNA甲基化是一种DNA的酶促共价修饰,一直是主要研究的表观遗传机制之一。单胺类神经递质的代谢酶,单胺氧化酶A/B()是研究DNA甲基化在精神障碍中作用的主要候选对象。在本综述中,我们将回顾单胺氧化酶(MAO)的结构和生理功能的最新进展,简要叙述其他因素,包括应激诱导的变化、早年生活应激、围产期抑郁症(PD)与其他表观遗传变化,如DNA甲基化、微小RNA(miRNA)的关系。本综述将阐明MDD中涉及的表观遗传变化,这可能为未来抑郁症发病机制的治疗提供潜在靶点。